Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

Journal

Publication Venue For

  • Patient outcomes improve when a molecular signature test guides treatment decision-making in rheumatoid arthritis..  1-10. 2022
  • Clinical utility of therapy selection informed by predicted nonresponse to tumor necrosis factor-ɑ inhibitors: an analysis from the Study to Accelerate Information of Molecular Signatures (AIMS) in rheumatoid arthritis.  22:101-109. 2022
  • A profile of the binx health io® molecular point-of-care test for chlamydia and gonorrhea in women and men.  21:861-868. 2021
  • A profile of the cobas® CT/NG assay on the cobas® 6800/8800 system for detection of Chlamydia trachomatis and Neisseria gonorrhoeae.  20:375-380. 2020
  • A profile of the cobas® TV/ MG test for the detection of Trichomonas vaginalis and Mycoplasma genitalium.  20:381-386. 2020
  • We have the technology, but should we build the test?.  18:917-919. 2018
  • Molecular diagnosis of antimicrobial resistance in Escherichia coli..  18:207-217. 2018
  • Genetics of polycystic ovary syndrome.  17:723-733. 2017
  • Profile of the triplex assay for detection of chlamydia, gonorrhea and trichomonas using the BD MAX™ System.  17:539-547. 2017
  • Clinical performance of the Solana® Point-of-Care Trichomonas Assay from clinician-collected vaginal swabs and urine specimens from symptomatic and asymptomatic women.  17:303-306. 2017
  • Type-specific detection of herpes simplex virus type 1 and type 2 using the cobas® HSV 1 and 2 test on the cobas® 4800 platform.  16:1145-1154. 2016
  • Cobas® 4800: A fully automated system for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae.  13:131-140. 2013
  • Diagnosis of herpes simplex virus infections of the CNS.  5:537-547. 2005
  • Biomarkers in melanoma: Stage III and IV disease.  5:65-74. 2005
  • Biomarkers in melanoma: Staging, prognosis and detection of early metastases.  3:303-330. 2003
  • Biomarkers in melanoma: Predisposition, screening and diagnosis.  3:163-184. 2003
  • International Standard Serial Number (issn)

  • 1473-7159
  • Electronic International Standard Serial Number (eissn)

  • 1744-8352